← Open Payments lookup

SHIRLEY MOORJANI: Open Payments

NPI 1952844664 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,537 in 97 payments from 14 companies in 2025. Trend: 2023 $1,851 · 2024 $1,599 · 2025 $2,537

Food & beverage: $2,537
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.22$556
E.R. Squibb & Sons, L.L.C.10$436
Alkermes, Inc.14$348
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$346
Neurocrine BioSciences, Inc.15$296
Teva Pharmaceuticals USA, Inc.10$208
Vanda Pharmaceuticals Inc.3$90
ABBVIE INC.4$67
Axsome Therapeutics, Inc.2$46
Tris Pharma Inc1$32

Products named: COBENFY, REXULTI, ARISTADA, CAPLYTA, INGREZZA, AUSTEDO XR, ABILIFY MAINTENA, FANAPT.

Industry payments across NV — which companies pay providers there.